Assessment of  -adrenergic blocking and non-specific properties of propranolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004594:Electrophysiology; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000166:cytology; D005082:Physical Exertion; D011433:Propranolol / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011433:Propranolol